Erratum: Outcomes of Trimodal Therapy for cT2-3 Urothelial Carcinoma in a Racially Diverse Population: A Single Institution Experience in the Bronx (Bladder Cancer (2020) 6: 4 (453-460) DOI: 10.3233/BLC-200332)

In the funding section on page 459 the authors have reported no sources of funding related to this article. However, this is incorrect and the funding details should specified in the funding section with the following text: Grant support for A. Sankin provided by NIH LRP (L30 CA220768), 7/2017-6/2020. As such, the updated Funding section, as well as the sections of Acknowledgements, Author Contributions and Conflicts of Interest of this article are provided below. ACKNOWLEDGMENTS The authors have no acknowledgments. FUNDING Grant support for A. Sankin provided by NIH LRP (L30 CA220768), 7/2017-6/2020 AUTHOR CONTRIBUTIONS Collection and Assembly of Data: Gottlieb Study Concept and Design: Sankin, Kovac, Schoenberg Statistical Analysis: Kovac, Gottlieb Analysis and Interpretation of Data: Sankin, Kovac, Gottlieb Drafting of Manuscripts: Gottlieb, Sankin Manuscript Revision: Sankin, Kovac, Schoenberg, Aboumohamed, Gartrell, Bodner, Garg Final Approval of Manuscript: All authors CONFLICTS OF INTEREST The authors have no conflicts of interest.